Molecular Data Inc
NASDAQ:MKD
Molecular Data Inc
Total Receivables
Molecular Data Inc
Total Receivables Peer Comparison
Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Molecular Data Inc
NASDAQ:MKD
|
Total Receivables
¥92m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Total Receivables
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pinduoduo Inc
NASDAQ:PDD
|
Total Receivables
¥12.6B
|
CAGR 3-Years
31%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
|
JD Health International Inc
HKEX:6618
|
Total Receivables
¥2B
|
CAGR 3-Years
54%
|
CAGR 5-Years
136%
|
CAGR 10-Years
N/A
|
|
Meituan
HKEX:3690
|
Total Receivables
¥13.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
JD.Com Inc
HKEX:9618
|
Total Receivables
¥20.5B
|
CAGR 3-Years
6%
|
CAGR 5-Years
14%
|
CAGR 10-Years
45%
|
See Also
What is Molecular Data Inc's Total Receivables?
Total Receivables
92m
CNY
Based on the financial report for Dec 31, 2020, Molecular Data Inc's Total Receivables amounts to 92m CNY.
What is Molecular Data Inc's Total Receivables growth rate?
Total Receivables CAGR 3Y
-3%
Over the last year, the Total Receivables growth was -56%. The average annual Total Receivables growth rates for Molecular Data Inc have been -3% over the past three years .